810145P
Avanti
18:1 NBD PE
Avanti Research™ - A Croda Brand
Synonym(s):
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Recommended Products
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (810145P-1mg)
pkg of 5 × 1 mg (810145P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
shipped in
dry ice
storage temp.
−20°C
General description
18:1 NBD PE is a fluorescently labelled lipid, containing unsaturated C18:1Δ9-acyl chains.
Application
18:1 NBD PE is suitable for:
- preparing liposomes
- fluorescence spectra study
- labelling giant unilamellar vesicles
Biochem/physiol Actions
L-α-Phosphatidylethanolamine (PE) is essential for maintaining the structural integrity of membranes.
Packaging
5 mL Amber Glass Screw Cap Vial (810145P-1mg)
5 mL Amber Glass Screw Cap Vial (810145P-5mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
also commonly purchased with this product
Storage Class Code
11 - Combustible Solids
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Black Lipid Membranes: Challenges in Simultaneous Quantitative Characterization by Electrophysiology and Fluorescence Microscopy
Langmuir (2019)
Assembling responsive microgels at responsive lipid membranes
Proceedings of the National Academy of Sciences of the USA, 116(12), 5442-5450 (2019)
A Janus-faced IM30 ring involved in thylakoid membrane fusion is assembled from IM30 tetramers
Structure, 25(9), 1380-1390 (2017)
Fusion of single proteoliposomes with planar, cushioned bilayers in microfluidic flow cells
Nature Protocols, 7(5), 903-903 (2012)
Pharmaceutics, 12(4) (2020-04-23)
Liposomes are biocompatible nanocarriers with promising features for targeted delivery of contrast agents and drugs into the tumor microenvironment, for imaging and therapy purposes. Liposome-based simultaneous targeting of tumor associated fibroblast and the vasculature is promising, but the heterogeneity of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service